Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies.

MLA

Xi Chen, et al. “Prophylactic Efficacy on Periprosthetic Bone Loss in Calcar Region after Total Hip Arthroplasty of Antiosteoporotic Drugs: A Network Meta-Analysis of Randomised Controlled Studies.” Postgraduate Medical Journal, vol. 97, no. 1145, Mar. 2021, pp. 150–55. EBSCOhost, https://doi.org/10.1136/postgradmedj-2019-137120.

APA

Xi Chen, Yu Shen, Chenyi Ye, Yishake Mumingjiang, Jinwei Lu, Yunxian Yu, Chen, X., Shen, Y., Ye, C., Mumingjiang, Y., Lu, J., & Yu, Y. (2021). Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies. Postgraduate Medical Journal, 97(1145), 150–155. https://doi.org/10.1136/postgradmedj-2019-137120

Chicago

Xi Chen, Yu Shen, Chenyi Ye, Yishake Mumingjiang, Jinwei Lu, Yunxian Yu, Xi Chen, et al. 2021. “Prophylactic Efficacy on Periprosthetic Bone Loss in Calcar Region after Total Hip Arthroplasty of Antiosteoporotic Drugs: A Network Meta-Analysis of Randomised Controlled Studies.” Postgraduate Medical Journal 97 (1145): 150–55. doi:10.1136/postgradmedj-2019-137120.